Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03B/oil-in-water emulsion-adjuvanted (AS03B) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age
Keyword(s):
2014 ◽
Vol 468
(1-2)
◽
pp. 187-195
◽
Keyword(s):
2015 ◽
Vol 12
(4)
◽
pp. 1009-1026
◽
Keyword(s):
2011 ◽
Vol 365
(15)
◽
pp. 1406-1416
◽
Keyword(s):
Keyword(s):